TOCTINO

This brand name is authorized in Austria, Canada, Estonia, Finland, France, Israel, Netherlands, Poland, Spain, UK.

Active ingredients

The drug TOCTINO contains one active pharmaceutical ingredient (API):

1	Alitretinoin UNII 1UA8E65KDZ - ALITRETINOIN
	Alitretinoin is a naturally-occurring endogenous hormone related to vitamin A, binds to and activates all known intracellular retinoid receptor subtypes (RAR, RAR, RAR, RXR, RXR, RXR). The efficacy of alitretinoin in treating KS lesions may be related to the demonstrated ability of alitretinoin to inhibit the in vitro growth of KS cells.
	Read more about Alitretinoin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TOCTINO Capsule, soft	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D11AH04	Alitretinoin	D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AH Agents for dermatitis, excluding corticosteroids
Discover more medicines within D11AH04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02337630, 02337649
EE	Ravimiamet	1405707, 1405718
ES	Centro de información online de medicamentos de la AEMPS	70843, 70844
FI	Lääkealan turvallisuus- ja kehittämiskeskus	126844, 484355
FR	Base de données publique des médicaments	64156738, 69219167
GB	Medicines & Healthcare Products Regulatory Agency	140604, 140612
IL	מִשְׂרַד הַבְּרִיאוּת	6701, 6702
NL	Z-Index G-Standaard, PRK	106682, 106690
PL	Rejestru Produktów Leczniczych	100236432, 100257687